search
Back to results

Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study (CC-POCA)

Primary Purpose

Cardiac Arrest

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
REBOA catheter
Sponsored by
Ciusss de L'Est de l'Île de Montréal
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest focused on measuring REBOA, ROSC, Cardiac arrest

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • - Patients aged 18-75 years old
  • Suspected reversible cause of cardiac arrest (except for trauma), with one of any of the following prognostic signs30

    • Reactive pupils
    • Agonal breathing
    • EtCO2>10 mmHg
    • Any cardiac activity on bedside echocardiogram
  • Body habitus accommodating automated Lund University Cardiac Arrest System (LUCAS)
  • Level of care includes CPR, or unable to obtain level of care (if possible, validate with relative)
  • More than 15 minutes of ACLS with no ROSC or more than 30 minutes of BLS with no ROSC

Exclusion Criteria:

  • Transfer accepted for ECPR

    • History of severe dementia
    • Advance Medical Directives against resuscitation
    • History of aortic pathology or surgery
    • LUCAS not compatible with the patient's body habitus
    • Pregnancy
    • Any illness resulting in loss of independent living capacity
    • Severe cardiopulmonary disease
    • Aortic dissection, aortic aneurysm, tension pneumothorax or tamponade seen on TEE/TTE
    • Strangulation
    • Suspected intracerebral hemorrhage
    • Accidental hypothermia
    • More than 60 minutes of resuscitation

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    interventional

    Arm Description

    20 patients with inclusion criteria and without exclusion criteria will be entered in the interventional arm attempting to use REBOA during non-traumatic cardiac arrest.

    Outcomes

    Primary Outcome Measures

    success rate and time of REBOA inflation during non-traumatic arrest in a community hospital
    ● Feasibility of intra-arrest REBOA catheter placement and zone 1 inflation in NTCA in a community hospital setting

    Secondary Outcome Measures

    blood pressure
    Systolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min) Diastolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
    ETCO2
    (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
    cerebral saturation
    (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
    ROSC
    return of spontaneous circulation
    TEE-guided REBOA positioning
    success rate of determining REBOA placement by trans esophageal echocardiography
    7 day survival
    follow up to 7 days

    Full Information

    First Posted
    March 28, 2022
    Last Updated
    April 6, 2022
    Sponsor
    Ciusss de L'Est de l'Île de Montréal
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05326789
    Brief Title
    Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study
    Acronym
    CC-POCA
    Official Title
    Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    May 1, 2022 (Anticipated)
    Primary Completion Date
    May 1, 2023 (Anticipated)
    Study Completion Date
    August 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Ciusss de L'Est de l'Île de Montréal

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Our general objective, during this study, is to evaluate the feasibility and potential physiological benefits of using REBOA (resuscitative endovascular balloon occlusion of the aorta) CPR (cardiopulmonary resuscitation) for patients presenting with a cardiac arrest to a community hospital. This would represent the first step for doing a larger, randomized clinical trial on the use of REBOA in non-traumatic cardiac arrest.
    Detailed Description
    Primary objective: Validate the feasibility of using REBOA in a community hospital setting during cardiac arrest as an adjunct to ACLS (advances cardiac life support) . This will be done by measuring time to REBOA placement and successful inflation. Furthermore, we will also document any REBOA related complications. Secondary objectives: Evaluate the potential physiological benefits of REBOA for human subjects in NTCA (non traumatic cardiac arrest) that are not responding to standard ACLS. Study Design and Methodology Trial design The trial is a single-center, single-arm, open (unblinded), feasibility, experimental study. Study Duration The study is expected to begin in winter 2022 and last approximately 12 months. Population studied The population studied will be patients in non-traumatic cardiac arrest at Santa Cabrini Hospital, aged 18-75 years old. Patients presenting with a witnessed cardiac arrest (out of hospital cardiac arrest (OHCA) or in hospital cardiac arrest (IHCA)) and in which ACLS was performed for at least 15 minutes or BLS for at least 30 minutes and for no more than 60 minutes will be evaluated for eligibility to participate in the study. Number of patients 20

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cardiac Arrest
    Keywords
    REBOA, ROSC, Cardiac arrest

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    single-center, single-arm, open (unblinded), feasibility, experimental study
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    interventional
    Arm Type
    Experimental
    Arm Description
    20 patients with inclusion criteria and without exclusion criteria will be entered in the interventional arm attempting to use REBOA during non-traumatic cardiac arrest.
    Intervention Type
    Device
    Intervention Name(s)
    REBOA catheter
    Other Intervention Name(s)
    resuscitative endovascular balloon occlusion of the aorta
    Intervention Description
    balloon occlusion of the aorta during cardiac arrest to optimize coronary and cerebral perfusion.
    Primary Outcome Measure Information:
    Title
    success rate and time of REBOA inflation during non-traumatic arrest in a community hospital
    Description
    ● Feasibility of intra-arrest REBOA catheter placement and zone 1 inflation in NTCA in a community hospital setting
    Time Frame
    1 year
    Secondary Outcome Measure Information:
    Title
    blood pressure
    Description
    Systolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min) Diastolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
    Time Frame
    0-15 min per study over a year
    Title
    ETCO2
    Description
    (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
    Time Frame
    0-15 min per study over a year
    Title
    cerebral saturation
    Description
    (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
    Time Frame
    0-15 min per study over a year
    Title
    ROSC
    Description
    return of spontaneous circulation
    Time Frame
    0-30 min per study over a year
    Title
    TEE-guided REBOA positioning
    Description
    success rate of determining REBOA placement by trans esophageal echocardiography
    Time Frame
    5 minutes per study over 1 year
    Title
    7 day survival
    Description
    follow up to 7 days
    Time Frame
    7 days over a year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: - Patients aged 18-75 years old Suspected reversible cause of cardiac arrest (except for trauma), with one of any of the following prognostic signs30 Reactive pupils Agonal breathing EtCO2>10 mmHg Any cardiac activity on bedside echocardiogram Body habitus accommodating automated Lund University Cardiac Arrest System (LUCAS) Level of care includes CPR, or unable to obtain level of care (if possible, validate with relative) More than 15 minutes of ACLS with no ROSC or more than 30 minutes of BLS with no ROSC Exclusion Criteria: Transfer accepted for ECPR History of severe dementia Advance Medical Directives against resuscitation History of aortic pathology or surgery LUCAS not compatible with the patient's body habitus Pregnancy Any illness resulting in loss of independent living capacity Severe cardiopulmonary disease Aortic dissection, aortic aneurysm, tension pneumothorax or tamponade seen on TEE/TTE Strangulation Suspected intracerebral hemorrhage Accidental hypothermia More than 60 minutes of resuscitation
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Philippe Rola, MD
    Phone
    15142177892
    Email
    philipperola@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Lawrence Leroux, MD
    Phone
    15148894644
    Email
    lawrence.leroux.1@gmail.com

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study

    We'll reach out to this number within 24 hrs